May 20, 2019
BIOTEM enters into collaboration with CALIXAR for the development of therapeutic antibodies against membrane targets
BIOTEM, a key player in the development of monoclonal antibodies of excellence, is pleased to announce the launch of a collaboration with CALIXAR, an innovative company specialized in the isolation and production of native and functional membrane proteins (MP).